Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Zimmer Biomet Shoulder Arthroplasty PMCF

NCT: NCT04984291 · RECRUITING

NCT IDNCT04984291
StatusRECRUITING
Start Date2021-07-28
Completion2033-08-15

Brief Summary

The objectives of this study are to confirm the safety, performance, and clinical benefits of Zimmer Biomet Shoulder Arthroplasty Systems and its instrumentation in primary or revision shoulder arthroplasty. These objectives will be assessed using standard scoring systems, radiographic evidence, and adverse event records. Safety of the system will be assessed by monitoring the frequency an incidence of adverse events.

Frequently Asked Questions

What is Zimmer Biomet Shoulder Arthroplasty PMCF?

Zimmer Biomet Shoulder Arthroplasty PMCF is a clinical trial registered under NCT04984291. Current status: RECRUITING.

What is the status of NCT04984291?

The current status of NCT04984291 (Zimmer Biomet Shoulder Arthroplasty PMCF) is: RECRUITING.

When did Zimmer Biomet Shoulder Arthroplasty PMCF start?

Zimmer Biomet Shoulder Arthroplasty PMCF started on 2021-07-28.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.